Pi Pharma Intelligence to Receive Additional Investment from Oasis500
InvestmentsPi Pharma Intelligence has received a bridging investment from Oasis500, which marks the second investment during the last two years. This round has been launched to fuel the growth of Pi Pharma towards reaching new customers and diversifying its products offering. Pi Pharma Intelligence is now in exciting times with planned launch of its revolutionized Pi Insight version, this new version comes to transform the data into an actionable intelligence application, more over Pi insight is expanding its data acquisitions to cover more territories and attributes.
Dr Nimer Alkhatib will present “Biosimilars Utilization and Uptake in the Market” study in Jordan FDA Third international Conference on Pharmaceuticals
Jun, 2023
Dr Nimer Alkhatib will present “Biosimilars Utilization and Uptake in the Market” study in Jordan FDA Third international Conference on Pharmaceuticals
Pi Pharma Intelligence will be a Sliver Sponsor to GCC Regulatory Affairs Pharma Summit
Jan, 2024
Pi Pharma Intelligence will be a Sliver Sponsor to GCC Regulatory Affairs Pharma Summit
.png)
Discover how Artificial Intelligence is transforming the pharmaceutical landscape in the MENA region as our management team leads the conversation.
Feb, 2025
#ArtificialIntelligence #PharmaInnovation #MENARegion #DigitalCooperation #GCCSummit #PharmaceuticalIndustry #AIinPharma #LeadershipInsights #IndustryLeaders #PiPharmaIntelligence